For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211126:nRSZ7396Ta&default-theme=true
RNS Number : 7396T Aquis Exchange PLC 26 November 2021
26 November 2021
Aquis Exchange PLC
("Aquis" or the "Company")
Exercise of Share Options
and
Total Voting Rights
Aquis Exchange PLC (AIM: AQX), the exchange services group, announces that it
has received notification that certain employees have exercised options under
the Company's EMI Option Scheme over 1,859 ordinary shares of 10p each in the
Company ("Ordinary Shares") at an exercise price of £2.69 per Ordinary Share
and 1,333 Ordinary Shares at an exercise price of £3.55 per Ordinary Share.
Application has been made for 3,192 new Ordinary Shares to be admitted to
trading on AIM, which is expected to take place on 29 November 2021. The new
Ordinary Shares will rank pari pasu with the existing Ordinary Shares in
issue.
Total Voting Rights
In accordance with the provisions of the Disclosure Guidance and Transparency
Rules of the FCA, the Company confirms that, following this issue, its issued
share capital will comprise 27,505,449 Ordinary Shares. All Ordinary Shares
shall have equal voting rights and none of the Ordinary Shares are held in
treasury. Accordingly, the figure of 27,505,449 may be used by shareholders as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in the
Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Aquis Exchange PLC Tel: +44 (0) 7768 078 110
Belinda Keheyan, Head of Marketing
Liberum Capital Limited (Nominated Adviser and Joint Broker) Tel: +44 (0) 20 3100 2000
Chris Clarke
Clayton Bush
Edward Thomas
Kane Collings
Canaccord Genuity Limited (Joint Broker) Tel: +44 (0) 20 7523 8000
Bobbie Hilliam (Corporate Broking)
Alma PR (Financial PR Adviser) Tel: +44 (0)20 3405 0209
Susie Hudson aquis@almapr.co.uk
Kieran Breheny
Faye Calow
Notes to Editors
About Aquis Exchange
Aquis Exchange PLC is an exchange services group, which operates pan-European
cash equities trading businesses (Aquis Exchange), growth and regulated
primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange
software to third parties (Aquis Technologies).
Aquis Exchange is authorised and regulated by the UK Financial Conduct
Authority and France's Autorité des Marchés Financiers to operate
Multilateral Trading Facility businesses in the UK and in EU27 respectively.
Aquis operates a lit order book and does not allow aggressive non-client
proprietary trading, which has resulted in lower toxicity and signalling risk
on Aquis than other trading venues in Europe. According to independent
studies, trades on Aquis are less likely to lead to price movement than on
other lit markets. Aquis uses a subscription pricing model which works by
charging users according to the message traffic they generate, rather than a
percentage of the value of each stock that they trade.
Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary
markets for equity and debt products. It is authorised as a Recognised
Investment Exchange, which allows it to operate a regulated listings venue.
AQSE, which used to be known as NEX Exchange Ltd., was acquired by Aquis in
March 2020 from CME Inc. The AQSE Growth Market is divided into two segments
'Access' and 'Apex', with different levels of admission criteria. The Access
market focuses on earlier stage growth companies, while Apex is the intended
market for larger, more established businesses.
Aquis Technologies is the software and technology division of Aquis Exchange
PLC. It creates and licenses cutting-edge, cost-effective matching engine and
trade surveillance technology for banks, brokers, investment firms and
exchanges.
Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of
the LSE (AIM) market. For more information, please go to www.aquis.eu
(https://protect-eu.mimecast.com/s/J6W1CWLkXujqqGXTx7PAm?domain=aquis.eu)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRDZMZMLVKGMZG